The output of medicinal preparations with respect to nine therapeutic groups (Table 3) was 1544 million dollars with respect to production volume in 1968 and reached 80.57% of all production by the Japanese pharmaceutical industry. It should be noted particularly that vitamins occupy the leading position (more than 14%) in the list of products of the Japanese pharmaceutical industry and that the manufacture of enz~Tnes and amino acids is increasing at a rapid pace.
There are 2771 pharmaceutical firms registered in Japan, 1026 of which employ more than four individuals; the 12 largest pharmaceutical companies accounted for 52% of all the pharmaceutical production in 1966. The number of workers employed in the pharmaceutical industry including temporary workers was 57,403, 68,440, and 84,820 in 1955, 1960, and 1965, respectively. In order to keep pace with progressive technology and to be competitive on the world market with respect to production quality and value, the manufacturers of Japanese pharmaceutical preparations are making huge investments in the reconstruction of currently operating plants and in the creation of new manufacturing capabilities. However, in recent years there has been a tendency to curtail them. Investments in the Japanese pharmaceutical industry in 1961, 1962, 1963, 1964, 1965, and1966 were 53.3, 65.3, 85.3, 95.8, 75.3, and 65 .3 million dollars, respectively. The increase in production is chiefly due to vaccines and blood substitutes
The Japanese pharmaceutical industry is one of the most profitable branches of the nation's industry. It widely takes advantage of the advances of foreign technique and technology in the manufacture of medicinal preparations both by the creation of joint companies with foreign firms which have definite technological processes as well as by inclusion of contracts of technical assistance with respect to individual industries.
In Japan there are currently 46 pharmaceutical companies which are either completely or partially owned by foreigners.
The Japanese pharmaceutical industry is especially interested in scientific research. The 12 largest Japanese pharmaceutical companies spent 27.8 million dollars in 1965 for scientific research as against 20.6 million dollars in 1964. Expenditures for scientific-research work in 1965 were 3.4% of the total obtained from the sale of pharmaceutical products. The number of scientists engaged in scientific research in these companies was 4061 in 1965 or 9.3% of the total number of workers. Japan has already discovered several medicinal substances which have received world recognition. Among these are eanamycin, mytomycin, trichomycin, active forms of thiamine, etc.
With respect to the consumption of medicinal preparations, which has been increasing sharply in recent years, Japan in 1965 captured fourth place among the capitalistic countries (Table 4 ).
The volume of production of medicinal preparations and the growth of the pharmaceutical industry depend to a significant degree on the number of doctors and pharmacologists in the country. They are those who examine and evaluatemedicinal preparations, recommend them to the ill, and carry out observations in the course of the treatment. Table 5 shows the number of practicing doctors and pharmacologists per 100,000 population in Japan and in other capitalistic countries. 
